Source: Virtual Congress 2020 – Risk factors for chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Axelsson (Gothenburg, Sweden), H. Backman (Luleå, Sweden), L. Vanfleteren (Gothenburg, Sweden), C. Stridsman (Luleå, Sweden), L. Ekerljung (Gothenburg, Sweden), B. Eriksson (Halmstad, Sweden), B. Nwaru (Gothenburg, Sweden), E. Rönmark (Umeå, Sweden), H. Kankaanranta (Seinäjoki, Finland), A. Lindberg (Umeå, Sweden), B. Lundbäck (Gothenburg, Sweden). Underdiagnosis and misclassification of COPD in Sweden. 1395

Member's Comments

No comment yet.

Related content which might interest you: The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Costs of COPD and asthma in Sweden Source: Eur Respir J 2004; 24: Suppl. 48, 701s Year: 2004 Underdiagnosis of COPD and associated cardiovascular comorbidity in the population- results from the Vancouver and Kentucky population BOLD study Source: Annual Congress 2008 - COPD and miscellaneous Year: 2008 Under-recognition of the severity of asthma and under-treatment of asthma in a rural area of Japan Source: Eur Respir J 2006; 28: Suppl. 50, 321s Year: 2006 Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 COPD medications and risk of pneumonia in the UK Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Incidence and risk factors of acute exacerbations of COPD in Italy Source: Eur Respir J 2001; 18: Suppl. 33, 152s Year: 2001 Incidence of asthma and COPD in a general population Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010 Use of medicines and prevalence of co-morbid diseases in subjects with and without COPD in Sweden Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Exacerbations and mortality of COPD patients with cardiovascular disease in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Symptoms of COPD in the general population are associated with overweight and obesity Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 COPD exacerbations in hypertensive patients in two ethnic groups in Macedonia Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Co-morbid asthma in COPD patients in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation Source: Eur Respir J 2006; 28: Suppl. 50, 449s Year: 2006 Estimates of chronic obstructive pulmonary disease in terms of prevalence, mortality and costs for England and Scotland for 2011 and 2030 Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 COPD exacerbations occur more frequently in women – Data from the Bergmannsheil cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 High prevalence and under-diagnosis of obstructive lung diseases in hospitalized patients in India Source: Eur Respir J 2005; 26: Suppl. 49, 594s Year: 2005 The prevalence of asthma and COPD in Italy: A practice-based study Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010